日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Therapeutic reprogramming of tumour-associated macrophages in pancreatic cancer using a cytotoxic CCR2-targeted nanotheranostic

利用靶向CCR2的细胞毒性纳米诊疗剂对胰腺癌肿瘤相关巨噬细胞进行治疗性重编程

Somani, Vikas Kumar; Zhang, Xiaohui; Chen, Timothy Hung-Po; Bulle, Ashenafi; Bansod, Sapana; Li, Lin; Geng, Yutong; Kang, Liang-I; Heo, Gyu Seong; Luehmann, Hannah; Zhang, Yuena; Saeed, Muhammad A; Lavine, Kory J; DeNardo, David G; Pachynski, Russell K; Liu, Yongjian; Lim, Kian-Huat

Targeted Thrombolysis via CCR2-Engineered Macrophage-Mimicking Microbubbles Safely Ablates Venous, Arterial, and Microvascular Thrombosis

利用CCR2工程化巨噬细胞模拟微泡进行靶向溶栓,可安全消融静脉、动脉和微血管血栓。

Li, Buying; Lu, Changjin; Gao, Shijie; Chen, Dandan; Heng, Xue; Mequanint, Kibret; Xing, Malcolm; Luo, Gaoxing; Li, Haisheng

Trajectory-Based Clustering to Identify Asthma Subgroups Responsive to the Selective CXCR2 Antagonist, AZD5069

基于轨迹的聚类分析识别对选择性CXCR2拮抗剂AZD5069有反应的哮喘亚组

Asamoah, Khezia; Yang, Freda; Adcock, Ian M; Vuckovic, Dragana; Uddin, Mohib; Chung, Kian Fan; Chadeau-Hyam, Marc

CCR2 Orchestrates Preferential Homing and Therapeutic Efficacy of Gingival Mesenchymal Stem Cell-Derived Extracellular Vesicles in Rheumatoid Arthritis

CCR2 调控牙龈间充质干细胞来源的细胞外囊泡在类风湿性关节炎中的优先归巢和治疗功效

Chen, Jingrong; Guan, Xiao; Wu, Wenbin; Wu, Luyao; Liu, Yan; Zeng, Donglan; Dang, Junlong; Zhao, Jun; Wang, Julie; Yuan, Jia; Fan, Xiaoli; Pan, Yunfeng; Olsen, Nancy; Zheng, Song Guo

Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer

一项针对晚期胰腺癌或结直肠癌患者的BMS-813160(一种CCR2/5双重拮抗剂)联合化疗或纳武利尤单抗的1b/2期研究

Le, Dung T; Folprecht, Gunnar; Varghese, Anna M; Gutierrez, Martin; Noel, Marcus; Trikalinos, Nikolaos A; Chen, Eric; Dayyani, Farshid; Davis, S Lindsey; Ma, Wen Wee; BasuMallick, Atrayee; Garrido-Laguna, Ignacio; Osawa, Mayu; O'Brien, Shaun; Novosiadly, Ruslan D; Xu, Ke; Greenawalt, Danielle M; Dutta, Santanu; Twyman Saint Victor, Christina; Lenz, Heinz-Josef

Non-enzymatic Rnaseh2c orchestrates proliferating macrophage-driven immunosuppression and HCC progression via Cdk9 proliferation axis and CCL2/CCR2-mediated CD8(+) T(ex) infiltration: a novel therapeutic paradigm with "Rnaseh2c-In1" inhibitor

非酶促RNA酶2c通过Cdk9增殖轴和CCL2/CCR2介导的CD8<sup>+</sup> T细胞浸润,调控增殖性巨噬细胞驱动的免疫抑制和肝细胞癌进展:一种以“RNA酶2c-In1”抑制剂为基础的新型治疗模式

Wang, Zengbin; Xiao, Ruiying; Liu, Mengxin; Ceng, Lihua; Lin, Zikun; Zheng, Xinyu; Shi, Miaoxin; Ye, Hong; Wu, Linqing; Tang, Nanhong

GPR35 protects against reperfusion injury in ischemic stroke by binding with the CR2 domain of Raf1.

GPR35 通过与 Raf1 的 CR2 结构域结合,防止缺血性中风中的再灌注损伤。

Li Xiaojun, Wang Qi, Cheng Qingyu, Zhou Jingyong, Qu Tingting, Xu Jianling, Du Yuming, Miao Bowen, Chen Yongquan, Yao Weidong, Wang Bin

CXCL7/CXCR2 in the paraventricular thalamus mediates obesity-related pain.

室旁丘脑中的 CXCL7/CXCR2 介导肥胖相关疼痛。

DHCR24 Deficiency Drives Age-Related Meibomian Gland Dysfunction by Regulating Lipid Metabolic Imbalance and Cytosolic mtDNA-Induced cGAS-STING Activation.

DHCR24 缺乏通过调节脂质代谢失衡和胞质 mtDNA 诱导的 cGAS-STING 激活驱动与年龄相关的睑板腺功能障碍。

Cai Yuchen, Zhou Tianyi, Sun Jiaming, Cai Xueyao, Shi Wenjun, Chen Junzhao, Zouboulis Christos C, Sun Hao, Fu Yao, Chen Liangbo

DHCR24 Drives Ovarian Cancer Chemoresistance Through Lipid Raft-mediated P-gp Stabilization and STAT3 Activation.

DHCR24 通过脂筏介导的 P-gp 稳定和 STAT3 激活驱动卵巢癌化疗耐药性。

Fu Xin, Wang Zhaosong, Yang Zhining, Xu Yue, Dong Qiuping, Cui Yanfen, Wang Ke